check_circleStudy Completed

Contraception, Ovulation Inhibition, Contraceptives, Oral

Bayer Identifier:

91288

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to evaluate the ovulation inhibitory effect of Minisiston® (0.03 mg Ethinylestradiol and 0.125 mg Levonorgestrel)

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
32
Trial Dates
March 2003 - July 2003
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Minisiston/Monostep (EE30/LNG, BAY86-4977)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Monocenter, open-label, uncontrolled study to evaluate the ovulation inhibitory effect of Minisiston® (0.03 mg Ethinyl estradiol and 0.125 mg Levonorgestrel), applied for two treatment cycles to 30 female volunteers
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.